Table 2.
Comparison of Postmenopausal Hormone Replacement Therapy to Statin and Aspirin Therapy on Coronary Heart Disease and Total Mortality in Primary Prevention*
| Outcome | Hormone Replacement Therapy# | Statin Therapy | Aspirin Therapy |
|---|---|---|---|
| Coronary Heart Disease | 0.68 (0.48–0.96)14 | 0.89 (0.69–1.09)1 | 1.01 (0.84–1.21)8 |
| 0.48 (0.26–0.87)19 | 0.95 (0.78–1.16)2 | 0.91 (0.80–1.03)9 | |
| 0.79 (0.56–1.13)4 | |||
| Total Mortality | 0.61 (0.39–0.95)20 | 0.95 (0.62–1.46)1 | 0.94 (0.74–1.19)8 |
| 0.72 (0.62–0.82)21 | 0.96 (0.81–1.13)2 | 0.95 (0.85–1.06)9 | |
| 0.57 (0.30–1.08)19 | 0.91 (0.76–1.08)4 |
Hazard Ratio (95% Confidence Interval)
Initiation in women <60 years old and/or <10 years-since-menopause